Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry.
Methods for analysis of T cell responses to specific antigen have traditionally relied on measurements of proliferation or cytokine expression in bulk cultures of PBMC in long term incubations with putative antigen. These techniques suffer from the drawback that they do not enable analysis of single cell responses in the context of unselected cellular backgrounds. It is increasingly important to not only identify cells on the basis of expression of unique surface antigens but also to determine functional and molecular parameters of individual cells in response to a variety of stimuli. We have recently developed methodologies to rapidly assess T-cell subset responses to polyclonal activators and specific antigen in whole blood. These procedures determine the percentages of activated cells and the identification of leucocyte subsets capable of expressing various cytokines and cell surface antigens. Multiparameter analysis of CD69+ /cytokine + expression in T cells in response to specific antigen (e.g. CMV, mumps) demonstrated a range of frequencies from 0.05% to 5.0% within 6 h. Frequencies of responding T cells were consistent but varied depending upon the antigen. Antigen specific T cell responses were host specific and both positively and negatively regulated by antibodies to co-receptors involved in APC-T cell interactions. These technologies will be discussed in terms of application to problems of measuring immune function parameters in disease. The modified technique described in this report is compatible with simple and rapid analysis of clinical samples and provides a means to directly examine the effects of in vivo drug concentrations on T cell immunity. Studies are in progress to examine the sensitivity of this cellular assay to drugs and other therapeutic modalities in clinical samples.
Maino
V C
VC
Becton Dickinson Immunocytometry Systems, San Jose, CA, USA.
D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000941:Antigens / Q000008:administration & dosage*; D000956:Antigens, Viral / Q000008:administration & dosage; D001773:Blood Cells / Q000166:cytology / Q000276:immunology; D016207:Cytokines / Q000096:biosynthesis* / Q000235:genetics; D003587:Cytomegalovirus / Q000276:immunology; D005434:Flow Cytometry / Q000379:methods*; D015870:Gene Expression; D000949:Histocompatibility Antigens Class II; D006801:Humans; D007156:Immunologic Memory; D007158:Immunologic Techniques; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D013194:Staining and Labeling / Q000379:methods; D013601:T-Lymphocytes / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
D000911:Antibodies, Monoclonal; D000941:Antigens; D000956:Antigens, Viral; D016207:Cytokines; D000949:Histocompatibility Antigens Class II